Status:

COMPLETED

Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

Lead Sponsor:

Eli Lilly and Company

Conditions:

Attention Deficit Hyperactivity Disorder

Eligibility:

All Genders

6-18 years

Phase:

PHASE2

PHASE3

Brief Summary

Atomoxetine versus placebo in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)

Eligibility Criteria

Inclusion

  • Patients are diagnosed with ADHD
  • Patients must be able to swallow capsules
  • Patients must be of normal intelligence

Exclusion

  • Patients who weigh less than 15 kg or more than 75 kg
  • Patients with organic brain disease (for example, dementia or traumatic brain injury residual)

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

End Date :

September 1 2006

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT00191295

Start Date

February 1 2005

End Date

September 1 2006

Last Update

November 6 2007

Active Locations (24)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (24 locations)

1

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

Aichi, Japan

2

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

Chiba, Japan

3

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

Fukui, Japan

4

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

Fukuoka, Japan